New developments in osteoarthritis pharmacological therapies.

Rheumatology (Oxford) · 2021 · PMC8709565 · PMID 34951922

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At 24 weeks, tanezumab 5 mg improved WOMAC pain, physical function and PGA of OA (PGA-OA) vs placebo; tanezumab 2.5 mg improved pain and function in patients but this did not reach statistical significance for PGA-OA.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.